Patent · US Active

Reverse transcriptase variants

US11932882B2 · kind B2 · utility

1Cited by
4References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 10, 2022
Grant dateMar 19, 2024
Priority date
Expiry dateJun 10, 2042

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Y207/07049
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The application provides compositions including engineered reverse transcriptases with at least one altered reverse-transcriptase related activity. The engineered reverse transcriptases or reverse transcription enzymes unexpectedly exhibit one or more altered reverse transcriptase related activities such as but not limited to altered template switching efficiency, altered transcription efficiency or both.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.